TP53 and neoplasm: This result held up in a model controlling for all 3 loci as well as TP53 IHC staining intensity and patient age and gender, where HOXB2 methylation was associated with an 8.6 fold increased risk of being an invasive tumor (95% CI 3.4, 21.7).